These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18671250)

  • 21. Epistasis analysis using multifactor dimensionality reduction.
    Moore JH; Andrews PC
    Methods Mol Biol; 2015; 1253():301-14. PubMed ID: 25403539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Power of multifactor dimensionality reduction and penalized logistic regression for detecting gene-gene interaction in a case-control study.
    He H; Oetting WS; Brott MJ; Basu S
    BMC Med Genet; 2009 Dec; 10():127. PubMed ID: 19961594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of internal model validation methods for multifactor dimensionality reduction in the case of genetic heterogeneity.
    Gory JJ; Sweeney HC; Reif DM; Motsinger-Reif AA
    BMC Res Notes; 2012 Nov; 5():623. PubMed ID: 23126544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unified Cox model based multifactor dimensionality reduction method for gene-gene interaction analysis of the survival phenotype.
    Lee S; Son D; Kim Y; Yu W; Park T
    BioData Min; 2018; 11():27. PubMed ID: 30564286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An "almost exhaustive" search-based sequential permutation method for detecting epistasis in disease association studies.
    Ma L; Assimes TL; Asadi NB; Iribarren C; Quertermous T; Wong WH
    Genet Epidemiol; 2010 Jul; 34(5):434-43. PubMed ID: 20583286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A robustness study of parametric and non-parametric tests in model-based multifactor dimensionality reduction for epistasis detection.
    Mahachie John JM; Van Lishout F; Gusareva ES; Van Steen K
    BioData Min; 2013 Apr; 6(1):9. PubMed ID: 23618370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifactor dimensionality reduction for graphics processing units enables genome-wide testing of epistasis in sporadic ALS.
    Greene CS; Sinnott-Armstrong NA; Himmelstein DS; Park PJ; Moore JH; Harris BT
    Bioinformatics; 2010 Mar; 26(5):694-5. PubMed ID: 20081222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An improved fuzzy set-based multifactor dimensionality reduction for detecting epistasis.
    Yang CH; Chuang LY; Lin YD
    Artif Intell Med; 2020 Jan; 102():101768. PubMed ID: 31980105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An empirical fuzzy multifactor dimensionality reduction method for detecting gene-gene interactions.
    Leem S; Park T
    BMC Genomics; 2017 Mar; 18(Suppl 2):115. PubMed ID: 28361694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifactor dimensionality reduction: an analysis strategy for modelling and detecting gene-gene interactions in human genetics and pharmacogenomics studies.
    Motsinger AA; Ritchie MD
    Hum Genomics; 2006 Mar; 2(5):318-28. PubMed ID: 16595076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extension of multifactor dimensionality reduction for identifying multilocus effects in the GAW14 simulated data.
    Mei H; Ma D; Ashley-Koch A; Martin ER
    BMC Genet; 2005 Dec; 6 Suppl 1(Suppl 1):S145. PubMed ID: 16451605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A fast and powerful W-test for pairwise epistasis testing.
    Wang MH; Sun R; Guo J; Weng H; Lee J; Hu I; Sham PC; Zee BC
    Nucleic Acids Res; 2016 Jul; 44(12):e115. PubMed ID: 27112568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ideal discrimination of discrete clinical endpoints using multilocus genotypes.
    Hahn LW; Moore JH
    In Silico Biol; 2004; 4(2):183-94. PubMed ID: 15107022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatial rank-based multifactor dimensionality reduction to detect gene-gene interactions for multivariate phenotypes.
    Park M; Jeong HB; Lee JH; Park T
    BMC Bioinformatics; 2021 Oct; 22(1):480. PubMed ID: 34607566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An efficient algorithm to perform multiple testing in epistasis screening.
    Van Lishout F; Mahachie John JM; Gusareva ES; Urrea V; Cleynen I; Théâtre E; Charloteaux B; Calle ML; Wehenkel L; Van Steen K
    BMC Bioinformatics; 2013 Apr; 14():138. PubMed ID: 23617239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DualWMDR: Detecting epistatic interaction with dual screening and multifactor dimensionality reduction.
    Cao X; Yu G; Ren W; Guo M; Wang J
    Hum Mutat; 2020 Mar; 41(3):719-734. PubMed ID: 31705708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of methods for detecting interacting loci.
    Chen L; Yu G; Langefeld CD; Miller DJ; Guy RT; Raghuram J; Yuan X; Herrington DM; Wang Y
    BMC Genomics; 2011 Jul; 12():344. PubMed ID: 21729295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Bayesian method for identifying genetic interactions.
    Visweswaran S; Wong AK; Barmada MM
    AMIA Annu Symp Proc; 2009 Nov; 2009():673-7. PubMed ID: 20351939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving strategies for detecting genetic patterns of disease susceptibility in association studies.
    Calle ML; Urrea V; Vellalta G; Malats N; Steen KV
    Stat Med; 2008 Dec; 27(30):6532-46. PubMed ID: 18837071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A screening methodology based on Random Forests to improve the detection of gene-gene interactions.
    De Lobel L; Geurts P; Baele G; Castro-Giner F; Kogevinas M; Van Steen K
    Eur J Hum Genet; 2010 Oct; 18(10):1127-32. PubMed ID: 20461113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.